Peptide purity: what the HPLC percentage on a COA measures and what it misses
Peptide purity on a COA is an HPLC peak-area percentage, not a weight. A sample 97% pure by HPLC can be only 40% peptide once water and counter-ions are counted.
Peptide purity, as printed on most certificates of analysis, is an HPLC peak-area percentage. It reports what share of the detected material eluted as the main peak. It does not report how much of the powder's weight is the target peptide. That is a separate figure, net peptide content, and it is often much lower.
The gap matters for anyone comparing lots or calculating concentrations in the lab. A sample can be 97% pure by HPLC and still be less than half peptide by weight.
What a peptide purity percentage measures
Reversed-phase HPLC separates a dissolved sample on a column while a UV detector records each peak as it elutes. GenScript's QC training material defines purity as the target peptide's peak area relative to all detected peak area. A "97%" result means 97% of the integrated area sits under the main peak.
The remaining area belongs mostly to peptide-related impurities. FDA's 2021 guidance on synthetic peptides describes these as sequences related to the target but altered by insertion, deletion or modification, such as oxidation. Lax and Verlander of PolyPeptide Laboratories note that solid-phase synthesis also leaves truncated sequences in crude material. Most are removed during purification. The ones that remain are often close analogs of the target, which is why they are hard to separate. See solid-phase peptide synthesis for where these by-products come from.
What HPLC purity does not capture
Three things can be present in a vial without changing the purity figure at all.
- Water. Lyophilized peptides retain moisture. GenScript's overview puts water usually below 10% of gross weight, higher for hydrophilic sequences. Karl Fischer titration measures it.
- Counter-ions. Basic residues carry bound anions such as trifluoroacetate (TFA), acetate or chloride. GenScript puts counter-ions at roughly 10–30% of gross weight, depending on the number of basic residues. Ion chromatography measures them. Our LL-37 TFA post shows how large this can get for a cationic sequence.
- Co-eluting impurities. Lax and Verlander point out that a single HPLC method only shows impurities that separate from the main peak. Anything hidden under it is counted as product.
The same authors flag two impurity types as especially hard to catch. Enantiomers (D-amino acid forms) and β-aspartate isomers behave almost identically to the target and have identical or near-identical masses. Even LC-MS may not distinguish them.
Why the same sample can give different purity numbers
Purity is defined by the method, not just the sample. In the PolyPeptide example, one PACAP(1-38) sample was run two ways. A steep gradient at room temperature and a shallow gradient at 60 °C differed by 10 percentage points in peak purity.
Other variables shift the result too:
- Column age, since resolving power declines with use.
- Integration choices: how baseline drift is handled, where noise is cut off, and whether small peaks are dropped to baseline or skimmed tangentially.
- Mobile phase. The authors ran one GLP-2 sample in TFA, triethylammonium phosphate and KPF6 systems. A different ion pair can expose impurities another misses.
Their recommendation is at least two orthogonal HPLC methods, using different ion pairs or separation principles. They also suggest COAs include the actual chromatograms so readers can judge the integration. A useful piece of arithmetic from the same paper: moving from 95% to 97% purity cuts impurities from 5% to 3%. That is a 40% reduction in potentially interfering material.
Drug regulators set a much finer bar. For generic synthetic versions of five approved peptides, including liraglutide and teriparatide, FDA recommends high-resolution methods such as UHPLC-HRMS. Applicants should identify every peptide-related impurity at 0.10% or more. Any new impurity absent from the reference product should be no more than 0.5%. Those thresholds apply to generic drug applications, not research-grade material. Still, they show how far a single ">98%" figure is from a full impurity profile.
Peptide purity vs net peptide content
Net peptide content is the peptide's share of the gross powder weight. It is measured independently of HPLC purity, usually by amino acid analysis or nitrogen elemental analysis. Nitrogen analysis works because counter-ions and water contain no nitrogen. The full breakdown is in our guide to purity vs net peptide content.
| Measurement | What it reports | Typical method |
|---|---|---|
| HPLC purity | Main peak as a share of detected peak area | Reversed-phase HPLC with UV detection |
| Net peptide content | Peptide mass as a share of gross weight | Amino acid analysis or nitrogen analysis |
| Counter-ion content | TFA, acetate or chloride by weight | Ion chromatography |
| Water content | Residual moisture by weight | Karl Fischer titration |
| Impurity identity | Mass and structure of individual peaks | LC-MS; FDA cites UHPLC-HRMS |
GenScript's worked example shows how the two numbers combine. A 10 mg vial with 40% peptide content holds 4.0 mg of peptide. At 97% purity, 3.88 mg of that is the target sequence.
Counter-ions alone can pull content down sharply. AmbioPharm's example peptide has a molecular weight of 1,000 and two TFA-binding sites, at 114 each. Its theoretical net content is 1000 / 1228, or 81%. GenScript's 1,500 Da example with four bound TFA ions works out to 23.3% TFA by weight. Real samples run lower than the theoretical figure because water and residual solvent add mass. More on the salt forms is in counter-ions: TFA vs acetate.
Reading the purity line on a COA
A purity number is easier to interpret when the COA answers a few questions.
- Is the HPLC method stated: column, gradient, temperature and wavelength?
- Is the chromatogram attached, with integration visible?
- Was more than one orthogonal method used?
- Does a mass spectrum confirm the main peak's identity?
- Is net peptide content, counter-ion content or water reported, or only purity?
Our guides on how to read a COA and HPLC and mass spec walk through each section. The COA checker flags missing fields, and peptide quantification methods covers the content assays in more depth.
Sources
- FDA: ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin, guidance for industry (May 2021)
- Chimica Oggi / Chemistry Today: Lax R, Verlander M. Are low-priced peptides affordable? (July/August 2006)
- GenScript: Examining the components of your peptide sample with AccuPep QC, Lauren Lu (October 2015)
- AmbioPharm: How is theoretical net peptide content calculated? (FAQ)
Educational content only, not medical advice. Compounds discussed as research materials are for laboratory research use only and are not for human or veterinary use.
More from the blog
- Health Canada finds bacteria in seized peptide vials: the November 2026 advisories
- What is a peptide bond? Resonance, cis/trans isomers and how it forms and breaks
- Cagrilintide: what the amylin analog's trials show and where FDA review stands
- AMA urges HHS to rescind its peptide compounding policy as the comment period closes